Trait Conscientiousness and Multiple Sclerosis: Predicting Disease Progression and Assessing the Effects of an App-Supported Behavioral Intervention

被引:0
|
作者
Jaworski, Michael [1 ]
Sanivasci, Celeste [1 ]
Mirmosayyeb, Omid [1 ]
Fuchs, Tom A. [2 ]
Hulst, Hanneke [3 ]
Weinstock, Zachary [1 ]
Dwyer, Michael [1 ]
Jakimovski, Dejan [4 ]
Bergsland, Niels [4 ]
Eckert, Svetlana [4 ]
Hojnacki, David [4 ]
Zivadinov, Robert [4 ]
Weinstock-Guttman, Bianca [4 ]
Benedict, Ralph [4 ]
机构
[1] SUNY Buffalo, Jacobs Sch Med, Neurol, Buffalo, NY USA
[2] VU, Amsterdam, Netherlands
[3] Leiden Univ, Inst Psychol Hlth Med & Neuropsychol, Leiden, Netherlands
[4] SUNY Buffalo, Jacobs Sch Med, Buffalo, NY USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P395/3219
引用
收藏
页码:1080 / 1080
页数:1
相关论文
共 33 条
  • [31] Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects
    de Lago, Eva
    Moreno-Martet, Miguel
    Cabranes, Ana
    Ramos, Jose A.
    Fernandez-Ruiz, Javier
    NEUROPHARMACOLOGY, 2012, 62 (07) : 2299 - 2308
  • [32] Parenteral cladribine in patients with relapsing-remitting multiple sclerosis: results of a 2-year, double-blind, placebo-controlled, cross-over study to assess effects on relapses and disease progression
    Grieb, P.
    Stelmasiak, Z.
    Solski, J.
    Nowicki, J.
    Jakubowska, B.
    Ryba, M.
    JOURNAL OF NEUROLOGY, 2008, 255 : 180 - 180
  • [33] An open label trial comparing the effects of IFNB-1a (Rebif®), (Avonex®), IFNB-1b (Betaferon®) and glatiramer acetate (Copaxone®) on the relapse rate, lesion load on MRI and disease progression in patients with relapsing-remitting multiple sclerosis
    Oztekin, N. S.
    Oztekin, M. F.
    Yilmaz, O.
    Polat, R.
    MULTIPLE SCLEROSIS JOURNAL, 2006, 12 : S194 - S194